Saturday 17 October 2026
Export SINT’s income statement to Excel — free account
SINTX TECHNOLOGIES, INC.
SINT Healthcare Medical Devices
SINTX TECHNOLOGIES, INC.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 million, down 64.7% from fiscal 2024. In the quarter to June 2026, revenue grew 199.3%, EPS grew 17.6%, free cash flow fell 38.6% and total debt fell 6.42%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.74
0.03
−1.69%
Follow SINT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
2 | 2 | 2 | 2 |
+8 more TTM periods Free account |
| (429.26%) | (503.49%) | (500.75%) | (343.31%) | ||
| (192.88%) | (182.89%) | (180.59%) | (146.14%) | ||
ROIC |
(548.06%) | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(422.27%) | (3,106.17%) | (713.87%) | (466.04%) | |
Average Days of Receivables |
90.29 | 129.12 | 63.82 | 34.49 | |
Free Cash Flow per Share |
(2.13) | (2.38) | (3.03) | (2.46) | |
Free Cash Flow |
(10.34) | (9.54) | (8.41) | (7.29) | |
Capital Expenditures |
(0.22) | 0.22 | 0.16 | 0.06 | |
| Other line items | |||||
Cash ROIC |
(121.29%) | (329.15%) | (118.82%) | (70.27%) | |
Accounts Receivable Turnover |
6.24 | 4.46 | 5.44 | 5.52 | |
Accounts Payable Turnover |
1.12 | 1.08 | 1.64 | 3.42 | |
Inventory Turnover |
0.48 | 0.60 | 0.84 | 1.34 | |
Average Days of Payables |
543.72 | 381.01 | 250.32 | 121.67 | |
Days of Inventory on Hand |
1,310.97 | 930.18 | 540.62 | 267.91 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
238.35% | 372.69% | 450.59% | 340.71% | |
Selling, General and Administrative Expense of Revenue |
690.90% | 780.76% | 632.51% | 469.37% | |
Share Based Compensation of Revenue |
182.11% | 228.28% | 196.07% | 106.46% | |
Interest Coverage |
(301.74) | (226.37) | (206.17) | (187.69) | |
Operating CF/Net income |
0.53 | 0.55 | 0.50 | 0.44 | |
Depreciation/Fixed assets |
1.45 | 1.51 | 1.39 | 1.43 | |
Capex/Depreciation |
(0.34) | 0.35 | 0.25 | 0.08 | |
Revenue per Share |
0.27 | 0.26 | 0.37 | 0.43 | |
Operating CF per Share |
(2.09) | (2.43) | (3.09) | (2.48) | |
Capex per Share |
(0.04) | 0.05 | 0.06 | 0.02 | |
Capex to Sales |
0.16 | (0.21) | (0.16) | (0.05) |
Columns are period end dates